Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
FLGC 
Flora Growth Corp (FLGC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
10/29/2025: FLGC (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
2 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $30
1 Year Target Price $30
| 1 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -93.47% | Avg. Invested days 21 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/29/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 8.28M USD | Price to earnings Ratio - | 1Y Target Price 30 |
Price to earnings Ratio - | 1Y Target Price 30 | ||
Volume (30-day avg) 2 | Beta 1.92 | 52 Weeks Range 10.14 - 81.90 | Updated Date 10/29/2025 |
52 Weeks Range 10.14 - 81.90 | Updated Date 10/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -34.71 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -24.96% | Operating Margin (TTM) -17.34% |
Management Effectiveness
Return on Assets (TTM) -30.57% | Return on Equity (TTM) -212.2% |
Valuation
Trailing PE - | Forward PE 7.89 | Enterprise Value 19146760 | Price to Sales(TTM) 0.16 |
Enterprise Value 19146760 | Price to Sales(TTM) 0.16 | ||
Enterprise Value to Revenue 0.37 | Enterprise Value to EBITDA -1 | Shares Outstanding 712355 | Shares Floating 571942 |
Shares Outstanding 712355 | Shares Floating 571942 | ||
Percent Insiders 10.18 | Percent Institutions 3.31 |
Upturn AI SWOT
Flora Growth Corp
Company Overview
History and Background
Flora Growth Corp was founded in 2019 and focuses on building a vertically integrated cannabis business across multiple countries. The company has focused on strategic acquisitions and partnerships to expand its reach and product offerings.
Core Business Areas
- Flora Pharma: Focused on manufacturing pharmaceutical-grade cannabis products and distribution to global markets, including medical cannabis and prescription medications.
- Flora Beauty: Focused on developing and marketing cannabis-infused beauty and skincare products.
- House of Brands: Includes portfolio of lifestyle brands such as Vessel and JustCBD.
Leadership and Structure
The company is led by CEO Clifford Starke. The organizational structure consists of various departments and teams responsible for different aspects of the business, including cultivation, processing, product development, sales, and marketing.
Top Products and Market Share
Key Offerings
- Cannabis Flower: High-quality cannabis flower grown in Colombia. Market share data is not readily available. Competitors include other large-scale cannabis growers such as Curaleaf and Trulieve.
- Cannabis-Infused Beauty Products: Cannabis-infused skincare and beauty products under the Flora Beauty brand. Market share data is not readily available. Competitors include Sephora and Ulta Beauty.
- Vessel Brand: Vessel offers luxury vaporizer devices and accessories. Market share data is not readily available. Competitors PAX Labs, G Pen, and Dr. Dabber.
Market Dynamics
Industry Overview
The cannabis industry is experiencing rapid growth, driven by increasing legalization and changing consumer attitudes. The market is highly competitive and subject to evolving regulations.
Positioning
Flora Growth Corp is positioned as a vertically integrated cannabis company with a focus on international markets and diverse product offerings. Its competitive advantages include low-cost cultivation in Colombia and strategic partnerships.
Total Addressable Market (TAM)
The global cannabis market is projected to reach hundreds of billions of dollars in the coming years. Flora Growth Corp aims to capture a significant share of this market by expanding its operations and product portfolio. Estimated to be around $200-300B by 2030. They are in early growth stage.
Upturn SWOT Analysis
Strengths
- Low-cost cultivation in Colombia
- Vertically integrated supply chain
- Diverse product portfolio
- Strategic partnerships and acquisitions
- International market presence
Weaknesses
- Limited brand recognition
- Reliance on regulatory approvals
- High operating expenses
- Limited Financial Resources
- Dilution from financings
Opportunities
- Expansion into new international markets
- Increased legalization of cannabis
- Development of new cannabis-based products
- Strategic acquisitions and partnerships
- Growth of the cannabis-infused beauty market
Threats
- Intense competition
- Evolving regulations
- Fluctuations in cannabis prices
- Economic downturns
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- TLRY
- CGC
- CRON
Competitive Landscape
Flora Growth Corp competes with established cannabis companies and smaller players in various markets. Its advantages include low-cost cultivation and strategic partnerships, while its disadvantages include limited brand recognition and reliance on regulatory approvals.
Major Acquisitions
Just Brands LLC (JustCBD)
- Year: 2022
- Acquisition Price (USD millions): 16
- Strategic Rationale: Expanded the company's portfolio to include edibles and CBD products.
Growth Trajectory and Initiatives
Historical Growth: Growth has been driven by acquisitions and expansion into new markets.
Future Projections: Future growth is projected to be driven by increasing cannabis legalization and expansion into new markets. Analyst estimates vary. Check analyst website and financial institutions.
Recent Initiatives: Recent initiatives include strategic acquisitions and partnerships to expand the company's product portfolio and market reach.
Summary
Flora Growth Corp is a vertically integrated cannabis company with a focus on international markets and diverse product offerings. The company has strengths in low-cost cultivation and strategic partnerships, but also faces challenges related to brand recognition and regulatory approvals. To continue the path to growth, Flora Growth Corp needs to be aware of potential threats such as competition and market pricing. They have to focus on strategic acquisitions and product quality to make themselves more valuable
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Company Website
- Industry Reports
Disclaimers:
This analysis is based on publicly available information and should not be considered financial advice. Market conditions and company performance may change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Flora Growth Corp
Exchange NASDAQ | Headquaters Fort Lauderdale, FL, United States | ||
IPO Launch date 2021-05-11 | CEO & Director Mr. Daniel Reis-Faria | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 64 | Website https://www.floragrowth.com |
Full time employees 64 | Website https://www.floragrowth.com | ||
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. The company operates in three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. It cultivates, processes, and supplies medicinal-grade cannabis flower, as well as cannabis derived medical and wellness products. The company also offers food and beverage, nutraceutical, cannabis accessories and technology, personal care, and wellness products; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; and cannabis consumption accessories, as well as personal storage and travel accessories for the vape and dry herbs. In addition, it manufactures and distributes pharmaceutical goods and medical cannabis products to treat a range of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brand names. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.